USANA Health Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Operating Leases (Tables)

Operating Leases (Tables)

9 Months Ended

Sep. 28, 2019

Operating Leases [Abstract]

Summary Of Lease Assets And Lease Liabilities In The Balance Sheet



				As of
Leases		Classification		September 28, ‎2019
Assets
ROU operating lease assets, net		Other assets		$	25,434
Total ROU assets				$	25,434

Liabilities
Current:
Operating lease liabilities		Other current liabilities		$	7,158
Non-current:
Operating lease liabilities		Other long-term liabilities		$	12,574
Total lease liabilities				$	19,732

Supplemental Lease Information



		Quarter Ended			Nine Months Ended
		September 28,			September 28,
		2019			2019
Lease cost
Operating lease cost		$	2,153		$	6,647
Total lease cost		$	2,153		$	6,647



					Nine Months Ended
					September 28,
					2019
Other information
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases					$	6,403
ROU assets obtained in exchange for new operating lease liabilities					$	6,207
Weighted-average remaining lease term—operating leases						3.82 yrs.
Weighted-average discount rate—operating leases						3.76%

Maturity Analysis For Operating Lease Liabilities



Year ending
Remainder of 2019				$	2,145
2020					7,659
2021					5,115
2022					2,241
2023					1,650
Thereafter					2,609
				$	21,419
Less: imputed interest				$	(1,687)
Present value				$	19,732

Schedule Of Future Commitments Under Operating Leases



Year ending
2019	$	9,155
2020		6,146
2021		3,825
2022		1,962
2023		1,464
Thereafter		2,514
	$	25,066